AeroLeads people directory · profile
Jesse Smith Email & Phone Number
Independent Consultant
at
NextRNA Therapeutics
1 work email found
@epizyme.com
5 phones found area 617
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Independent Consultant
Location
Cambridge, Massachusetts, United States
Who is Jesse Smith? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Jesse Smith is listed as Independent Consultant at NextRNA Therapeutics, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at epizyme.com, phone signal with area code 617, and a matched LinkedIn profile for Jesse Smith.
Jesse Smith previously worked as Chief Scientific Officer at Nextrna Therapeutics and Independent Consultant at Self-Employed. Jesse Smith holds Ph.D., Molecular Cancer Biology, Cell Biology from Duke University.
Company email context
Email format at NextRNA Therapeutics
This section adds company-level context without repeating Jesse Smith's masked contact details.
{first_initial}{last}@epizyme.com
86% confidence
AeroLeads found 1 current-domain work email signal for Jesse Smith. Compare company email patterns before reaching out.
Profile bio
About Jesse Smith
Over 20 years of industry experience in targeted drug discovery. Expertise in the fields of cancer biology, epigenetics, and small molecule drug discovery. Significant experience in other therapeutic areas, such as metabolic disease, inflammatory disease, and beta hemoglobinopathies. Major contributions to eight IND submissions, one CTA filing, more than 35 publications and four patents. Excellence in leadership, communication and R&D strategy.
Listed skills include Assay Development, Drug Discovery, Biotechnology, Cell Biology, and 12 others.
Current workplace
Jesse Smith's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 24 years
Jesse Smith work experience
A career timeline built from the work history available for this profile.
Chief Scientific Officer
Current
Sep 2024 - Present
Independent Consultant
Self-Employed
Consulting services for drug discovery, disease biology, company creation, etc.
Oct 2023 - Sep 2024
Chief Scientific Officer
Mar 2022 - Oct 2023
Senior Vice President Of Translational Sciences
Jan 2020 - Mar 2022
Senior Vice President Of Early Discovery
Aug 2018 - Nov 2019
Vice President Of Biological Sciences
Epizyme
- Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme is focused on the discovery and development of inhibitors of histone.
- Department head for group of 25 biologists, responsible for target validation, computational biology, cell-based assay development, in vivo cancer biology (lead optimization), translational biology, and clinical PD.
- Championed Epizyme’s first non-oncology drug discovery program: G9A developmental candidate for the treatment of sickle cell disease (to be presented at ASH, 2017)
- Responsible for communicating company’s scientific vision and status updates to diverse audiences: investors, BD, PR, KOLs and broader scientific community (2015-)
- Member of Executive Leadership Team
- Member of GSK Alliance Joint Steering Committee
Jan 2013 - Aug 2018
Director, Biological Sciences
Epizyme
Head of Platform Biology Group-Target identification and validation
Jun 2010 - Jun 2018
Associate Director Of Biology
Catabasis Pharmaceuticals
Dec 2008 - Jun 2010
Associate Director
- Team Leader, Cell Biology Group.
- Managed 2 Ph.D. and 2-3 Research Associates
- Developed 3 novel cell based assays for profiling small molecule SIRT1 activators in support of SAR efforts
- Lead efforts to utilize systems biology approach to elucidate the molecular mechanisms underlying compound efficacy in vivo
- Co-recipient of Bio-IT World’s 2008 Best Practices Award in the Drug Discovery category
- Identified and validated mechanism-based biomarker for SIRT1 activators in pre-clinical models of metabolic disease
Oct 2005 - Dec 2008
Investigator
Arqule
- Target Research Group; studied the targets and mechanism of action of ARQ 501, a Phase II clinical trial cancer therapeutic
- Identified an ARQ 501 molecular target in cell culture systems
- Elucidated ARQ 501 molecular mechanism of action
- Developed two assays based on ARQ 501 MOA for use in profiling next-generation leads from ARQ 501’s chemical family
- Developed a clinical assay for monitoring ARQ 501 cytotoxicity in clinical samples
- Managed one Research Associate
Feb 2004 - Oct 2005
Scientist I
Akceli
- Responsible for the development of cellular microarray technology
- Developed a novel, multiplexed GPCR assay using the Akceli platform
- Adapted assays for cell cycle arrest, proliferation, and apoptosis for use with cellular microarray technology
- Adapted RNAi technology to the cellular microarray platform
- Performed data mining on cellular microarray experiments
- Optimized the cellular microarray printing process
2002 - 2004
~2 yrs
2 education records
Jesse Smith education
Ph.D., Molecular Cancer Biology, Cell Biology
Duke University
B.S., Biochemistry And Molecular Biology
The University Of Georgia
FAQ
Frequently asked questions about Jesse Smith
Quick answers generated from the profile data available on this page.
What company does Jesse Smith work for?
Jesse Smith works for NextRNA Therapeutics.
What is Jesse Smith's role at NextRNA Therapeutics?
Jesse Smith is listed as Independent Consultant at NextRNA Therapeutics.
What is Jesse Smith's email address?
AeroLeads has found 1 work email signal at @epizyme.com for Jesse Smith at NextRNA Therapeutics.
What is Jesse Smith's phone number?
AeroLeads has found 5 phone signal(s) with area code 617 for Jesse Smith at NextRNA Therapeutics.
Where is Jesse Smith based?
Jesse Smith is based in Cambridge, Massachusetts, United States while working with NextRNA Therapeutics.
What companies has Jesse Smith worked for?
Jesse Smith has worked for Nextrna Therapeutics, Self-Employed, Civetta Therapeutics, Remix Therapeutics, and Omega Therapeutics.
How can I contact Jesse Smith?
You can use AeroLeads to view verified contact signals for Jesse Smith at NextRNA Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Jesse Smith attend?
Jesse Smith holds Ph.D., Molecular Cancer Biology, Cell Biology from Duke University.
What skills is Jesse Smith known for?
Jesse Smith is listed with skills including Assay Development, Drug Discovery, Biotechnology, Cell Biology, Cell Culture, Cancer, Clinical Development, and Clinical Trials.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial